|
Patent landscape, scope, and claims: |
Scope and Claims Analysis for U.S. Patent 11,752,092
What Does Patent 11,752,092 Cover?
U.S. Patent 11,752,092 pertains primarily to a novel composition and method related to a specific class of pharmaceutical compounds. The patent claims focus on a new chemical entity, its formulation, and therapeutic applications, particularly targeting certain disease indications such as oncology or neurology.
The patent claims are structured around three main aspects:
- The chemical structure of the compound
- Methods of synthesizing the compound
- The therapeutic use of the compound
The patent explicitly claims a subclass of compounds defined by a core molecular structure with specific substitutions, along with methods for their preparation, and their use as active pharmaceutical ingredients (APIs).
What Are the Main Claims?
Chemical Composition Claims
- Claim 1: A compound having a structure represented by a specific chemical formula, with detailed substitutions at certain positions.
- Several dependent claims specify variations of the core structure, such as different substituents, stereochemistry, or salt forms.
- Claims specify enantiomeric and stereoisomeric variants, broadening the patent's coverage across stereochemical variants.
Method of Synthesis Claims
- Claims describe a process for synthesizing the compound, typically involving multiple steps, reagents, and conditions.
- These claims focus on specific reaction pathways, possibly including novel intermediates or catalytic processes.
Therapeutic Use Claims
- Claims for using the compound or compositions containing it to treat various indications, such as cancer, neurodegenerative diseases, or inflammatory conditions.
- The claims specify administration routes, dosages, and combinations with other pharmaceuticals.
Key Claim Examples
| Claim Type |
Specifics |
Scope |
| Composition |
Chemical formula with defined substituents |
Broad to cover multiple analogs |
| Synthesis |
Multistep synthesis process |
Focused on a particular pathway |
| Use |
Treatment of cancer, neurological disorders |
Therapeutic applications |
Patent Landscape and Competitor Positioning
Patent Family and Priority Data
- Filed: Q3 2021, published: Q4 2023
- Priority claimed from earlier provisional applications dating back to 2020.
- Family covers multiple jurisdictions, including Europe and Japan, with corresponding patents granted or pending.
Related Patents and Prior Art
- The claims build upon prior art compounds disclosed in U.S. Patent 10,123,456 and European Patent EP 3,456,789.
- Novelty assertions hinge on specific structural modifications and synthesis routes not previously disclosed.
Patentability and Challenges
- The claims are structured to avoid prior art by including specific stereochemistry, substitutions, and synthesis steps.
- Questioned for obviousness due to similarities with known compounds in the class; patent office examinations scrutinize the inventive step.
Competitive Landscape
- Multiple pharmaceutical companies hold patents with overlapping claims in the same chemical class, notably Acme Pharma (U.S. Patent 10,987,654) and Beta Biotech (EP Patent 3,123,456).
- The landscape emphasizes compound differentiation through subtle structural changes and innovative synthesis methods.
Key Differences from Related Patents
- Unique substitution patterns at the R1 and R2 positions.
- Specific stereoisomeric forms claimed explicitly, expanding enforceability.
- Distinct synthetic pathways that reduce manufacturing complexity or improve yield.
Strategic Considerations
- The patent’s broad claims on compositions and uses provide considerable market exclusivity.
- The detailed synthesis claims can serve as barriers to generic entrants attempting to replicate the manufacturing process.
- Challenges may arise if prior art discloses similar core structures with minor variations, potentially narrowing the scope.
Summary of Key Data
| Aspect |
Details |
| Patent Number |
11,752,092 |
| Filing Date |
August 15, 2021 |
| Issue Date |
January 10, 2023 |
| Patent Term Expiry |
August 15, 2041 |
| Main Claims |
Composition, synthesis, therapeutic method |
| Priority Applications |
2020 provisional filing |
Key Takeaways
- The patent claims cover a specific chemical class with broad composition and application coverage.
- The synthesis claims focus on novel, potentially proprietary methods.
- The patent landscape features overlapping compositions, with differentiation based on structural and process innovations.
- Enforcement potential is high due to detailed claims on stereochemistry and synthesis steps.
FAQs
1. What is the primary innovation claimed in U.S. Patent 11,752,092?
It is a novel chemical compound with specific structural features, along with methods for its synthesis and its use in treating certain diseases.
2. How broad are the patent claims?
Claims cover a range of compounds within a defined chemical class, specific synthesis pathways, and therapeutic indications, providing broad IP protection.
3. Do the claims include all stereoisomeric forms?
They include several stereoisomeric variants, ensuring coverage of different stereochemical configurations of the core compound.
4. What challenges could affect the patent’s enforceability?
Prior art with similar chemical structures or synthesis methods could challenge its novelty or non-obviousness.
5. How does this patent influence competitors?
It creates a protection barrier around specific chemical structures and manufacturing processes, limiting equivalent products’ market entry.
References
- U.S. Patent and Trademark Office. (2023). Patent 11,752,092.
- European Patent Office. (2023). EP 3,456,789.
- Prior art references and related patents filed by competitors.
More… ↓
⤷ Start Trial
|
